Agomab Therapeutics Nv Adr stock is traded at $8.07, with a volume of 10,537. It is up +15.78% in the last 24 hours and down -8.71% over the past month. AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Previous Close:
$6.97
Open:
$7.09
24h Volume:
10,537
Relative Volume:
0.05
Market Cap:
$397.43M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-$0.6724
Net Cash Flow:
-
1W Performance:
+7.74%
1M Performance:
-8.71%
6M Performance:
-34.07%
1Y Performance:
0.00%
1-Day Range:
$7.01$8.09
1-Week Range:
$6.46$8.11
52-Week Range:
$6.46$17.82
Agomab Therapeutics Nv Adr Stock (AGMB) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS